CMS Halts New DME Suppliers to Fight Fraud

Overview of the CMS Moratorium

The Trump administration announced a nationwide moratorium on new durable medical equipment (DME) suppliers on Wednesday, February 26, 2026. Centers for Medicare and Medicaid Services (CMS) Administrator Mehmet Oz made the announcement alongside Vice President JD Vance and Health Secretary Robert F. Kennedy, Jr. Together, they cited rampant “fraud, waste, and abuse” as the driving force behind this bold decision.

Oz did not mince words at the press conference. “The amount of fraud is so massive that it’s easier to open one of these suppliers than to open a bank account,” he stated. This moratorium marks a significant move by the administration to tighten oversight of an industry that serves millions of seniors and people with disabilities.

Why CMS Acted Against DME Suppliers

The Fraud Problem Was Too Large to Ignore

CMS based its decision on a thorough analysis of current and historical Medicare enrollment and claims data. Findings from that review prompted officials to publish a Federal Register notice outlining the scope of the problem.

Although DME suppliers represent a small fraction of CMS’s $1.7 trillion annual budget, the sector consistently produces disproportionate levels of fraud. Federal investigators have uncovered improper payments time and again, signaling a systemic issue that demanded action. Furthermore, the ease with which fraudulent companies could register as suppliers added urgency to the decision.

Which Equipment and Suppliers Are Affected

Items That Seniors and Disabled Patients Rely On

The moratorium targets new DMEPOS suppliers — companies that provide durable medical equipment, prosthetics, orthotics, and supplies. Specifically, affected items include:

• Oxygen tanks
• Urinary catheters
• Gauze and wound care supplies
• Breast prostheses for postmastectomy patients
• Wheelchairs and artificial limbs

Importantly, the pause does not halt the distribution of medical equipment to existing patients. Current suppliers continue to operate normally. However, no new suppliers can enter the Medicare market during this period. This distinction is critical, as many vulnerable patients depend on these supplies for daily health management.

History of Fraud in the DME Industry

A Pattern of Improper Payments

The DME sector has a well-documented history of fraud within Medicare billing. Federal investigations have revealed significant financial losses over multiple time periods:

• Between 2015 and 2017, Medicare improperly paid $34 million to DME suppliers.
• Between 2018 and 2024, improper payments reached $22.7 million over seven years.

These figures, while modest relative to CMS’s full budget, represent real taxpayer dollars lost to fraudulent activity. Moreover, they suggest that prior corrective measures were insufficient. CMS has previously used moratoriums to address fraud in home health agencies and ambulance suppliers, making this approach a tested tool in its compliance arsenal.

How Long Will the Pause Last

A Six-Month Starting Point

The current moratorium runs for six months. However, federal law permits additional six-month extensions, meaning the pause could continue well beyond its initial window. Administrator Oz did not specify performance targets or benchmarks CMS aims to meet before lifting the moratorium. This open-ended structure gives regulators flexibility but also raises questions about the timeline for new suppliers seeking to enter the market.

Additional Fraud-Fighting Measures

New Tools to Combat Abuse

Beyond the DME moratorium, federal health leaders announced two additional anti-fraud initiatives at Wednesday’s press conference:

First, CMS plans to launch a dedicated fraud tipline, giving patients, providers, and industry insiders a direct channel to report suspected abuse. This move reflects a broader effort to engage the public in identifying fraudulent activity.

Second, the administration announced a temporary halt on $259.5 million in Medicaid funding to Minnesota. Officials cited fraud concerns as the justification. This action signals that the administration is willing to use funding leverage across multiple program areas to enforce compliance.

What This Means for Patients

Vulnerable Populations Face Uncertainty

The moratorium most directly affects seniors and people with disabilities who rely on DME for daily living. While existing suppliers continue to operate, the freeze on new entrants could reduce competition over time. Consequently, patients in underserved areas may face limited supplier options during and after the moratorium period.

Advocacy groups and disability rights organizations are likely to monitor the situation closely. The equipment covered — from oxygen tanks to prosthetics — represents life-sustaining support for many Americans. Therefore, the balance between fighting fraud and preserving patient access will be a central concern as this policy unfolds.